<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03454360</url>
  </required_header>
  <id_info>
    <org_study_id>2016-03</org_study_id>
    <nct_id>NCT03454360</nct_id>
  </id_info>
  <brief_title>CHANGE Neo™ TA Registry With ACURATE Neo™ Aortic Bioprosthesis and ACURATE Neo™ TA Transapical Delivery System</brief_title>
  <official_title>Collection of Specific Health And Patient Related Criteria Used to Select traNsapical TAVI Treatment and correspondinG outcomEs: CHANGE Neo™ TA Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Symetis SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this registry is to collect specific health and patient data to identify more
      precisely the patient population undergoing TA aortic valve replacement with the ACURATE neo™
      Aortic biprosthesis and ACURATE neo™ TA Transapical Delivery System.

      Safety and efficacy data will be collected to support the commercial use of the ACURATE neo™
      Aortic Bioprosthesis and ACURATE neo™ TA Transapical Delivery System in a specific TA
      population.

      As per IFU, the ACURATE neo™ and its ACURATE neo™ TA Delivery System are intended for use in
      minimally invasive, transcatheter aortic valve replacement using transapical access in
      patients presenting with severe aortic valve stenosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Primary Objective of this post-market registry is to collect specific health and patient
      characteristics to understand the indication for TA-TAVI and to further evaluate the safety
      and performance of the ACURATE neo ™ Aortic Bioprosthesis and ACURATE neo™ TA Transapical
      Delivery System in a specific TA population, consisting of 200 consented patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2018</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>30 days</time_frame>
    <description>the rate of all-cause mortality as measured at 30-days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety and performance data will be collected to support the commercial use of the ACURATE neo ™ Aortic Bioprosthesis and ACURATE neo™ TA Transapical Delivery System in a specific TA population.</measure>
    <time_frame>Procedure to Discharge, 30 days and 12-months</time_frame>
    <description>Clinical events as defined per VARC 2 consensus document at procedure:
All cause mortality; Stroke; Myocardial Infarction; Bleeding complication; Acute kidney injury; Vascular complication; Conduction disturbances and arrhythmia; Other TAVI-related complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>Procedure to 24-hours</time_frame>
    <description>Defined as absence of intra-procedure mortality (procedure to 24H) AND absence of complications arising during implantation of the prosthetic valve such as: inability to properly seat the valve in the annulus; need for more than one implanted aortic bioprosthesis (valve-in-valve or ectopic deployment) or if a surgical aortic valve replacement is required to correct a severe aortic regurgitation or procedure complication. The procedure can be considered as success despite the presence of residual aortic regurgitation, which may be due to the anatomic configuration of the annulus or a calcific valvular annulus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Success</measure>
    <time_frame>Post-procedure to Discharge.</time_frame>
    <description>Defined as;
Absence of intra-procedure mortality (procedure to 24H) AND,
Correct positioning (placement in the annulus with no impairment of aortic bioprosthesis function) of a single prosthetic heart valve into the proper anatomical location AND,
Intended performance of the prosthetic heart valve assessed prior to discharge per local standard of care and defined as:
No prosthesis-patient mismatch (EAOi &gt;0.85 cm2/m2 or EAOi &gt;0.7 cm2/m2 for BMI ≥30 kg/m2) ) AND,
Mean aortic valve gradient &lt;20mmHg or peak velocity &lt; 3 m/s AND,
No moderate or severe prosthetic valve regurgitation.
For echo parameters for the performance assessment, a pre-discharge echo examination should be performed as per local standard of care. If echo parameter pre-discharge is missing, any echo parameter within 45 days post-procedure may be used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VARC 2 Composite Safety</measure>
    <time_frame>30-days</time_frame>
    <description>Defined as:
All-cause mortality
All stroke
Life-threatening bleeding
Acute Kidney Injury- Stage 2 or 3
Coronary Artery Obstruction requiring intervention
Major Vascular Complications
Valve-related dysfunction requiring repeat procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional improvement as per NYHA Functional Classification</measure>
    <time_frame>from baseline to, discharge, 30-days and 12-months follow-up.</time_frame>
    <description>Change on NYHA Class between baseline and different follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of EOA and mean Trans-prosthetic gradient</measure>
    <time_frame>from baseline to discharge, 30- days and 12 months follow-up</time_frame>
    <description>If the echo parameter pre-discharge is missing to assess the intended performance, any echo parameter data within 45-days post procedure may be used for the missing values;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Aortic Regurgitation</measure>
    <time_frame>post-procedure, prior to discharge, at 30-days and 12-months follow-up;</time_frame>
    <description>Change on Aortic Regurgitation over time at follow-up</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Aortic Stenosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ACURATE neo™ Aortic Bioprosthesis</intervention_name>
    <description>TAVI; Transcatheter Aortic Valve Replacement. Transapical Access.</description>
    <other_name>ACURATE neo™ TA Delivery System</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All subjects with severe aortic stenosis, for whom the transapical access is the most
        suitable approach as per heart-team consensus, who signed the Informed Consent Form (ICF)
        approved by the Independent Ethics Committee (IEC), and are deemed to be candidates to
        undergo transcatheter aortic valve implantation with the ACURATE neo™ Aortic Bioprosthesis
        and its Transapical Delivery System as per clinical practice at each participating site
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Symptomatic patients with severe aortic stenosis;

          -  Institution heart team determines that aortic valve replacement ACURATE neoTM device
             using its transapical delivery system is appropriate;

        Exclusion criteria:

        - Patients unable or unwilling to give inform consent;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Hilker, Prof.Dr.med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Regensburg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Zanon</last_name>
    <phone>+41798407006</phone>
    <email>sarah.zanon@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Näschen</last_name>
    <email>thomas.naeschen@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kerckhoff Klinik</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herz-und Gefäß-Kilink GmbH</name>
      <address>
        <city>Bad Neustadt an der Saale</city>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Krankenhausbetriebgesellschaft</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>D-32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum der Ruhr-Universität Bochum</name>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikim Essen</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Univesitätsklinikum Frankfurt- Klinik für Thorax, Herz und thorakale Gefæßchirurgie</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitäts-Herzzentrum Freiburg-Bad Krozingen</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Standort Giessen</name>
      <address>
        <city>Gießen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Helios Klinik Fur Herzzchirurgie Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76185</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München</name>
      <address>
        <city>München</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sana Herzchirurgie</name>
      <address>
        <city>Stuttgart</city>
        <zip>70174</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinik für Herz-und Thoraxchirurgie, SHG-Kliniken Völklingen</name>
      <address>
        <city>Volklingen</city>
        <zip>66333</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera-Università degli Studi di Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Camillo Forlanini</name>
      <address>
        <city>Roma</city>
        <zip>00152</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Basel - Herzchirurgie</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2017</study_first_submitted>
  <study_first_submitted_qc>March 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2018</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TAVI</keyword>
  <keyword>Transcatheter Aortic Valve Replacement</keyword>
  <keyword>Transcatheter Aortic Valve</keyword>
  <keyword>Transapical Access</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

